Breast cancer risk assessment and risk distribution in 3,491 Slovenian women invited for screening at the age of 50; a population-based cross-sectional study
This work is licensed under the Creative Commons Attribution 4.0 International License.
Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. 2020. [cited 2023 Feb 28]. Available at: https://gco.iarc.fr/todayFerlayJErvikMLamFColombetMMeryLPiñerosMLyon, FranceInternational Agency for Research on Cancer2020[cited 2023 Feb 28]. Available at: https://gco.iarc.fr/todaySearch in Google Scholar
Zadnik V, Primic Zakelj M, Lokar K, Jarm K, Ivanus U, Zagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017; 51: 47–55. doi: 10.1515/raon-2017-0008ZadnikVPrimic ZakeljMLokarKJarmKIvanusUZagarT.Cancer burden in Slovenia with the time trends analysis201751475510.1515/raon-2017-0008Open DOISearch in Google Scholar
Statistical Office of the Republic of Slovenia. [cited 2023 Feb 12]. Available at: www.stat.si[cited 2023 Feb 12]. Available at: www.stat.siSearch in Google Scholar
Winters S, Martin C, Murphy D, Shokar NK. Breast cancer epidemiology, prevention and screening. Prog Mol Biol Transl Sci 2017; 151: 1–32. doi: 10.1016/bs.pmbts.2017.07.002WintersSMartinCMurphyDShokarNK.Breast cancer epidemiology, prevention and screening201715113210.1016/bs.pmbts.2017.07.002Open DOISearch in Google Scholar
Pashayan N, Antoniou AC, Ivanus U, Esserman LJ, Easton DF, Widschwendter M, et al. Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nat Rev Clin Oncol 2020; 17: 687–705. doi: 10.1038/s41571-020-0388-9PashayanNAntoniouACIvanusUEssermanLJEastonDFWidschwendterMPersonalized early detection and prevention of breast cancer: ENVISION consensus statement20201768770510.1038/s41571-020-0388-9Open DOISearch in Google Scholar
World Health Organization, International Agency for Research on Cancer. IARC handbooks of cancer prevention. Volume 15. Breast Cancer Screening. Lyon: IARC; 2016.World Health Organization, International Agency for Research on CancerIARC handbooks of cancer prevention15LyonIARC2016Search in Google Scholar
European Commission Initiative on Breast Cancer; 2023. [cited 2023 May 2]. Available at: https://healthcare-quality.jrc.ec.europa.eu/ecibc2023[cited 2023 May 2]. Available at: https://healthcare-quality.jrc.ec.europa.eu/ecibcSearch in Google Scholar
Council Recommendation on strengthening prevention through early detection: a new EU approach on cancer screening replacing Council Recommendation 2003/878/EC. 2022/0290(NLE). Brussels: Council of the European Union; 2022. [cited 2023 May 2]. Available at: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548BrusselsCouncil of the European Union2022[cited 2023 May 2]. Available at: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_7548Search in Google Scholar
Canelo-Aybar C, Ferreira DS, Ballesteros M, Posso M, Montero N, Sola I, et al. Benefits and harms of breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer. J Med Screen 2021; 28: 389–404. doi: 10.1177/0969141321993866Canelo-AybarCFerreiraDSBallesterosMPossoMMonteroNSolaIBenefits and harms of breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer20212838940410.1177/0969141321993866Open DOISearch in Google Scholar
Román M, Sala M, Domingo L, Posso M, Louro J, Castells X. Personalized breast cancer screening strategies: a systematic review and quality assessment. PLoS One 2019; 14: e0226352. doi: 10.1371/journal.pone.0226352RománMSalaMDomingoLPossoMLouroJCastellsX.Personalized breast cancer screening strategies: a systematic review and quality assessment201914e022635210.1371/journal.pone.0226352Open DOISearch in Google Scholar
Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, et al. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999; 91: 1541–8. doi: 10.1093/jnci/91.18.1541CostantinoJPGailMHPeeDAndersonSRedmondCKBenichouJValidation studies for models projecting the risk of invasive and total breast cancer incidence1999911541810.1093/jnci/91.18.1541Open DOISearch in Google Scholar
Tice JA, Bissell MCS, Miglioretti DL, Gard CC, Rauscher GH, Dabbous FM, et al. Validation of the breast cancer surveillance consortium model of breast cancer risk. Breast Cancer Res Treat 2019; 175: 519–23. doi: 10.1007/s10549-019-05167-2TiceJABissellMCSMigliorettiDLGardCCRauscherGHDabbousFMValidation of the breast cancer surveillance consortium model of breast cancer risk20191755192310.1007/s10549-019-05167-2Open DOISearch in Google Scholar
Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23: 1111–30. doi: 10.1002/sim.1668TyrerJDuffySWCuzickJ.A breast cancer prediction model incorporating familial and personal risk factors20042311113010.1002/sim.1668Open DOISearch in Google Scholar
Lee A, Mavaddat N, Cunningham A, Carver T, Ficorella L, Archer S, et al. Enhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence. J Med Genet 2022; 59: 1206–18. doi: 10.1136/jmedgenet-2022-108471LeeAMavaddatNCunninghamACarverTFicorellaLArcherSEnhancing the BOADICEA cancer risk prediction model to incorporate new data on RAD51C, RAD51D, BARD1 updates to tumour pathology and cancer incidence20225912061810.1136/jmedgenet-2022-108471Open DOISearch in Google Scholar
Carver T, Hartley S, Lee A, Cunningham AP, Archer S, Babb de Villiers C, et al. CanRisk Tool - a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants. Cancer Epidemiol Biomarkers Prev 2021; 30: 469–73. doi: 10.1158/1055-9965.EPI-20-1319CarverTHartleySLeeACunninghamAPArcherSBabb de VilliersCCanRisk Tool - a web interface for the prediction of breast and ovarian cancer risk and the likelihood of carrying genetic pathogenic variants2021304697310.1158/1055-9965.EPI-20-1319Open DOISearch in Google Scholar
Jarm K, Kadivec M, Šval C, Hertl K, Primic Žakelj M, Dean PB, et al. Quality assured implementation of the Slovenian breast cancer screening programme. PLoS One 2021; 16: e0258343. doi: org/10.1371/journal.pone.0258343JarmKKadivecMŠvalCHertlKPrimic ŽakeljMDeanPBQuality assured implementation of the Slovenian breast cancer screening programme202116e0258343doi: org/10.1371/journal.pone.0258343Search in Google Scholar
Blatnik A, Perhavec A, Gazić B, Vidergar-Kralj B, Matos E, Ratoša I, et al. [Recommendations for diagnosis and treatment of patients with breast cancer 2021]. [Slovenian]. Digital repository of Slovenian research organizations. Institute of Oncology Ljubljana. ISBN 978-961-7029-42-0. [cited 2023 Jan 21]. Available at: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=14846BlatnikAPerhavecAGazićBVidergar-KraljBMatosERatošaIDigital repository of Slovenian research organizations. Institute of Oncology LjubljanaISBN 978-961-7029-42-0. [cited 2023 Jan 21]. Available at: https://dirros.openscience.si/IzpisGradiva.php?lang=slv&id=14846Search in Google Scholar
Zadnik V, Krajc M. [Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population]. [Slovenian]. Onkologija 2018; 22: 6–10. doi: 10.25670/oi2018-016onZadnikVKrajcM.[Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population]. [Slovenian]20182261010.25670/oi2018-016onOpen DOISearch in Google Scholar
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L, et al, editors. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition. Luxembourg: European Commission. Office for Official Publications of the European Communities; 2006.PerryNBroedersMde WolfCTörnbergSHollandRvon KarsaLeditors.Fourth editionLuxembourgEuropean Commission. Office for Official Publications of the European Communities2006Search in Google Scholar
Krajc M, Blatnik A, Kerševan T, Hotujec S. [Clinical pathway for patients’ care at the Department of clinical cancer genetics]. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana. [cited: 2023 May 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/klinicne_poti/Klinicna_pot_obravnave_pacienta_v_Ambulanti_za_onkolosko_genetsko_svetovanje_in_testiranje_2020.pdfKrajcMBlatnikAKerševanTHotujecS.LjubljanaInstitute of Oncology Ljubljana[cited: 2023 May 15]. Available at: https://www.onko-i.si/fileadmin/onko/datoteke/Strokovna_knjiznica/klinicne_poti/Klinicna_pot_obravnave_pacienta_v_Ambulanti_za_onkolosko_genetsko_svetovanje_in_testiranje_2020.pdfSearch in Google Scholar
Sickles EA, D’Orsi CJ, Bassett LW. ACR BI-RADS® mammography. In: ACR BI-RADS® Atlas. Breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013.SicklesEAD’OrsiCJBassettLWACR BI-RADS® mammographyIn:Reston, VAAmerican College of Radiology2013Search in Google Scholar
World Health Organization. Menopause. [cited 2023 June 21]. Available at: https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women%20experience%20menopause%20between,changes%20in%20the%20menstrual%20cycleWorld Health Organization[cited 2023 June 21]. Available at: https://www.who.int/news-room/fact-sheets/detail/menopause#:~:text=Most%20women%20experience%20menopause%20between,changes%20in%20the%20menstrual%20cycleSearch in Google Scholar
Brentnall AR, Cuzick J. Risk models for breast cancer and their validation. Stat Sci 2020; 35: 14–30. doi: 10.1214/19-STS729BrentnallARCuzickJRisk models for breast cancer and their validation202035143010.1214/19-STS729Open DOISearch in Google Scholar
Krajc M, Evans GD, Blatnik A, Lokar K, Žagar T, Tomšič S, et al. Screening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines - pilot study. Zdr Varst 2020; 18: 211–18. doi: 10.2478/sjph-2020-0027KrajcMEvansGDBlatnikALokarKŽagarTTomšičSScreening strategy modification based on personalized breast cancer risk stratification and its implementation in the national guidelines - pilot study2020182111810.2478/sjph-2020-0027Open DOISearch in Google Scholar
IBIS breast cancer evaluation tool. [cited: 2023 April 10]. Available at: https://ems-trials.org/riskevaluator/[cited: 2023 April 10]. Available at: https://ems-trials.org/riskevaluator/Search in Google Scholar
Evans DG, Astley S, Stavrinos P, Harkness E, Donnelly LS, Dawe S, et al. Improvement in risk prediction, early detection and prevention of breast cancer in the NHS Breast Screening Programme and family history clinics: a dual cohort study. Southampton, UK: NIHR Journals Library; 2016. doi: 10.3310/pgfar04110EvansDGAstleySStavrinosPHarknessEDonnellyLSDaweSSouthampton, UKNIHR Journals Library201610.3310/pgfar04110Open DOISearch in Google Scholar
Roux A, Cholerton R, Sicsic J, Moumjid N, French DP, Rossi PG, et al. Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial. BMC Cancer 2022; 22: 507. doi: 10.1186/s12885-022-09484-6RouxACholertonRSicsicJMoumjidNFrenchDPRossiPGStudy protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the “My Personal Breast Screening” (MyPeBS) randomised clinical trial20222250710.1186/s12885-022-09484-6Open DOISearch in Google Scholar
Evans DG, Donnelly LS, Harkness EF, Astley SM, Stavrinos P, Dawe S, et al. Breast cancer risk feedback to women in the UK NHS breast screening population. Br J Cancer 2016; 114: 1045–52. doi: 10.1038/bjc.2016.56EvansDGDonnellyLSHarknessEFAstleySMStavrinosPDaweSBreast cancer risk feedback to women in the UK NHS breast screening population201611410455210.1038/bjc.2016.56Open DOISearch in Google Scholar
Laza-Vásquez C, Martínez-Alonso M, Forné-Izquierdo C, Vilaplana-Mayoral J, Cruz-Esteve I, Sánchez-López I, et al. DECIDO Group. Feasibility and acceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial. Int J Environ Res Public Health 2022; 19: 10426. doi: 10.3390/ijerph191610426Laza-VásquezCMartínez-AlonsoMForné-IzquierdoCVilaplana-MayoralJCruz-EsteveISánchez-LópezIDECIDO GroupFeasibility and acceptability of personalized breast cancer screening (DECIDO Study): a single-arm proof-of-concept trial2022191042610.3390/ijerph191610426Open DOISearch in Google Scholar
Simonović S, Zadnik V, Hafner A. [Pilot testing of individual breast cancer risk tool at Breast centre Kranj]. [Slovenian]. Graduation thesis. Ljubljana: University of Ljubljana; 2017. [cited: 2023 March 20]. Available at: https://plus.cobiss.net/cobiss/si/sl/bib/2883451SimonovićSZadnikVHafnerAGraduation thesis.LjubljanaUniversity of Ljubljana2017[cited: 2023 March 20]. Available at: https://plus.cobiss.net/cobiss/si/sl/bib/2883451Search in Google Scholar
Oblak T, Zadnik V, Krajc M, Lokar K, Zgajnar J. Breast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40–49 years - could it be better? Radiol Oncol 2020; 54: 335–40. doi: 10.2478/raon-2020-0040OblakTZadnikVKrajcMLokarKZgajnarJBreast cancer risk based on adapted IBIS prediction model in Slovenian women aged 40–49 years - could it be better?2020543354010.2478/raon-2020-0040Open DOISearch in Google Scholar
University Hospital of South Manchester. Genesis breast cancer prevention centre. Research overview 2014/15. Manchester: NHS Foundation trust; 2015. [cited: 2023 May 1]. Available at: http://www.breastcentre.manchester.ac.uk/Portals/12/Documents/Genesis%20Research%20Overview%202015.pdfUniversity Hospital of South ManchesterManchesterNHS Foundation trust2015[cited: 2023 May 1]. Available at: http://www.breastcentre.manchester.ac.uk/Portals/12/Documents/Genesis%20Research%20Overview%202015.pdfSearch in Google Scholar
Esserman LJ; WISDOM Study and Athena Investigators. The WISDOM Study: breaking the deadlock in the breast cancer screening debate. NPJ Breast Cancer 2017; 3: 34. doi: 10.1038/s41523-017-0035-5EssermanLJWISDOM Study and Athena InvestigatorsThe WISDOM Study: breaking the deadlock in the breast cancer screening debate201733410.1038/s41523-017-0035-5Open DOISearch in Google Scholar
My personal breast screening (MyPeBS). US National Library of Medicine. ClinicalTrials.gov ID NCT03672331. [cited: 2023 March 22]. Available at: https://clinicaltrials.gov/ct2/show/record/NCT03672331My personal breast screening (MyPeBS)US National Library of Medicine[cited: 2023 March 22]. Available at: https://clinicaltrials.gov/ct2/show/record/NCT03672331Search in Google Scholar
National Institute for Health and Care Excellence. Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG164. NICE; 2013. [cited: 2023 March 1]. Available at: https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancerNational Institute for Health and Care ExcellenceFamilial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer CG1642013[cited: 2023 March 1]. Available at: https://www.nice.org.uk/guidance/cg164/chapter/Recommendations#surveillance-and-strategies-for-early-detection-of-breast-cancerSearch in Google Scholar
Augustinsson A, Ellberg C, Kristoffersson U, Borg Å, Olsson H. Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer. Acta Oncol 2018; 57: 595–603. doi: 10.1080/0284186X.2017.1404635AugustinssonAEllbergCKristofferssonUBorgÅOlssonHAccuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer20185759560310.1080/0284186X.2017.1404635Open DOISearch in Google Scholar
National Institute of Public Health. Data portal. [cited 2023 June 20]. Available at: https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal/?rxid=9e76cdb9-ec30-4a1a-a1c4-9fce467492a8National Institute of Public Health[cited 2023 June 20]. Available at: https://podatki.nijz.si/pxweb/sl/NIJZ%20podatkovni%20portal/?rxid=9e76cdb9-ec30-4a1a-a1c4-9fce467492a8Search in Google Scholar
Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227–36. doi: 10.1056/NEJMoa062790BoydNFGuoHMartinLJSunLStoneJFishellEMammographic density and the risk and detection of breast cancer20073562273610.1056/NEJMoa062790Open DOISearch in Google Scholar
Checka CM Chun JE, Freya SR, Lee J, Toth H. The relationship of mammographic density and age: implications for breast cancer screening. AJR 2012; 198: 292–5. doi: 10.2214/AJR.10.6049CheckaCMChunJEFreyaSRLeeJTothHThe relationship of mammographic density and age: implications for breast cancer screening2012198292510.2214/AJR.10.6049Open DOISearch in Google Scholar
Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, et al. Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst 2016; 106: 255. doi: 10.1093/jnci/dju255SpragueBLGangnonREBurtVTrentham-DietzAHamptonJMWellmanRDPrevalence of mammographically dense breasts in the United States201610625510.1093/jnci/dju255Open DOISearch in Google Scholar
Portnow LH, Georgian-Smith D, Haider I, Barrios M, Camden P, Bay CP, et al. Persistent inter-observer variability of breast density assessment using BI-RADS® 5th edition guidelines. Clinical Imaging 2022; 83: 21–7. doi: 10.1016/j.clinimag.2021.11.034PortnowLHGeorgian-SmithDHaiderIBarriosMCamdenPBayCPPersistent inter-observer variability of breast density assessment using BI-RADS® 5th edition guidelines20228321710.1016/j.clinimag.2021.11.034Open DOISearch in Google Scholar
Brentnall AR, Harkness EF, Astley SM, Donnelly LS, Stavrinos P, Sampson S. Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort. Breast Cancer Res 2015; 17: 147. doi: 10.1186/s13058-015-0653-5BrentnallARHarknessEFAstleySMDonnellyLSStavrinosPSampsonSMammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort20151714710.1186/s13058-015-0653-5Open DOISearch in Google Scholar
A short guide to cancer screening: increase effectiveness, maximize benefits and minimize harm. World Health Organization. Regional Office for Europe; 2022. [cited: 2023 May 1]. Available at: https://apps.who.int/iris/handle/10665/351396World Health Organization. Regional Office for Europe2022[cited: 2023 May 1]. Available at: https://apps.who.int/iris/handle/10665/351396Search in Google Scholar
Di Stefano F, Camussi E, Casnati G, Garena F, Ceresa M, Castagno R, et al. Communication of breast cancer risk and a personalized screening protocol: experience within the MyPeBS Study. [abstract]. Code: ICS18011-74. International Cancer Screening Network conference. Turin; 2023.Di StefanoFCamussiECasnatiGGarenaFCeresaMCastagnoRInternational Cancer Screening Network conferenceTurin2023Search in Google Scholar
Kurir Borovčić M, Jarm K, Kutnar V, Škrbec V, Torkar K, Šval C, et al. Programme DORA yearly report of 2021. [Slovenian]. Ljubljana: Institute of Oncology Ljubljana; 2022. [cited 2023 April 20]. Available at: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_Letno_porocilo_2021_WEB_apr_2022.pdfKurir BorovčićMJarmKKutnarVŠkrbecVTorkarKŠvalCLjubljanaInstitute of Oncology Ljubljana2022[cited 2023 April 20]. Available at: https://dora.onko-i.si/fileadmin/user_upload/Dokumenti/DORA_Letno_porocilo_2021_WEB_apr_2022.pdfSearch in Google Scholar